These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging. Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877 [TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of (99m)Tc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines. Yurt Lambrecht F; Durkan K; Ozgür A; Gündüz C; Avcı CB; Susluer SY J Drug Target; 2013 May; 21(4):383-8. PubMed ID: 23301856 [TBL] [Abstract][Full Text] [Related]
7. Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells. Noaparast Z; Hosseinimehr SJ; Piramoon M; Abedi SM J Drug Target; 2015; 23(6):497-505. PubMed ID: 25673264 [TBL] [Abstract][Full Text] [Related]
8. Comparative assessment of a Torabizadeh SA; Abedi SM; Noaparast Z; Hosseinimehr SJ Bioorg Med Chem; 2017 May; 25(9):2583-2592. PubMed ID: 28351606 [TBL] [Abstract][Full Text] [Related]
9. Monitoring therapeutic response of human ovarian cancer to trastuzumab by SPECT imaging with (99m)Tc-peptide-Z(HER2:342). Zhang J; Zhao X; Wang S; Wang N; Han J; Jia L; Ren X Nucl Med Biol; 2015 Jun; 42(6):541-6. PubMed ID: 25735223 [TBL] [Abstract][Full Text] [Related]
11. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin. von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875 [TBL] [Abstract][Full Text] [Related]
12. 99mTc-labeling of HYNIC-conjugated cyclic RGDfK dimer and tetramer using EDDA as coligand. Wang J; Kim YS; Liu S Bioconjug Chem; 2008 Mar; 19(3):634-42. PubMed ID: 18281926 [TBL] [Abstract][Full Text] [Related]
13. [Comparative study of the biodistribution of (99m)Tc-HYNIC-Lys3-Bombesin obtained with the EDDA/tricine and NA/tricine as coligands]. Hernández-Cairo A; Perera-Pintado A; Prats-Capote A; Batista-Cuellar JF; Casacó-Santana C Rev Esp Med Nucl Imagen Mol; 2012; 31(2):61-5. PubMed ID: 22305264 [TBL] [Abstract][Full Text] [Related]
14. [99mTc] HYNIC-hEGF, a potential agent for imaging of EGF receptors in vivo: preparation and pre-clinical evaluation. Babaei MH; Almqvist Y; Orlova A; Shafii M; Kairemo K; Tolmachev V Oncol Rep; 2005 Jun; 13(6):1169-75. PubMed ID: 15870939 [TBL] [Abstract][Full Text] [Related]
16. In vitro cell studies of technetium-99m labeled RGD-HYNIC peptide, a comparison of tricine and EDDA as co-ligands. Su ZF; He J; Rusckowski M; Hnatowich DJ Nucl Med Biol; 2003 Feb; 30(2):141-9. PubMed ID: 12623113 [TBL] [Abstract][Full Text] [Related]
17. Preliminary application of micro-SPECT/CT imaging by Zhang Y; Meng L; Li B; Tan H; Lin QY; Cheng D; Shi H Chem Biol Drug Des; 2019 Apr; 93(4):447-453. PubMed ID: 30381892 [TBL] [Abstract][Full Text] [Related]
18. Formulation and Preclinical Testing of Tc-99m-Labeled HYNIC-Glc-FAPT as a FAP-Targeting Tumor Radiotracer. Yang X; Li G; Ruan C; Hu K; Tang G Bioconjug Chem; 2023 Nov; 34(11):2133-2143. PubMed ID: 37874952 [TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of Gan Q; Song X; Zhang X; Zhang J Eur J Med Chem; 2020 Feb; 188():112032. PubMed ID: 31926467 [TBL] [Abstract][Full Text] [Related]
20. (99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors. Tran T; Engfeldt T; Orlova A; Sandström M; Feldwisch J; Abrahmsén L; Wennborg A; Tolmachev V; Karlström AE Bioconjug Chem; 2007; 18(6):1956-64. PubMed ID: 17944527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]